SCHEMBL17916111

SCHEMBL17916111

CC(C)(C)c1cccc(N2CCNCC2=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.45
SLC6A2 P23975 3/20 0.45
SLC6A3 Q01959 2/20 0.45
HTR3E A5X5Y0 2/20 0.42
HTR3B O95264 2/20 0.42
HTR2C P28335 2/20 0.42
HTR3A P46098 2/20 0.42
HTR3D Q70Z44 2/20 0.42
HTR3C Q8WXA8 2/20 0.42
SIGMAR1 Q99720 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HTR1D P28221 1/20 0.42
THRB P10828 2/20 0.41
MAPT P10636 1/20 0.41
NOTUM Q6P988 1/20 0.40
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HSD11B1 P28845 1/20 0.37
HTR6 P50406 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11916166 0.82 SLC6A2 (0.46) SLC6A4SLC6A2SLC6A3HTR3AALDH1A1
SCHEMBL12892216 0.81 ADRB1 (0.57) SLC6A4SLC6A2SLC6A3MAPTHSD11B1
SCHEMBL18367701 0.80 ALDH1A1 (0.45) ALDH1A1MAPTNOTUMHDAC4HDAC2
SCHEMBL1583660 0.79 POLB (0.49) SLC6A4SLC6A2SLC6A3HTR2CALDH1A1
SCHEMBL3657785 0.79 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3HTR3EHTR3B
SCHEMBL1663489 0.78 ADRB1 (0.59) SLC6A4SLC6A2SLC6A3HTR2CHTR3A
SCHEMBL13547897 0.78 ALDH1A1 (0.57) ALDH1A1MAPTTP53CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL2860102 0.78 SLC6A4 (0.57) SLC6A4SLC6A2SLC6A3HTR3EHTR3B
SCHEMBL1583042 0.78 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3HTR3EHTR3B
Hydrochloric Acid SCHEMBL1583755 0.78 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3HTR2CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695182-B2 Chemical compounds (derivatives) and their application for the treatment of oncological diseases LIMITED LIABILITY COMPANY “NATIONAL PHARMACEUTICAL TECHNOLOGIES” (RU) 2017-07-04 US disclosed
US-20160200729-A1 NEW CHEMICAL COMPOUNDS (DERIVATIVES) AND THEIR APPLICATION FOR THE TREATMENT OF ONCOLOGICAL DISEASES LIMITED LIABILITY COMPANY (RU) 2016-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160200729-A1 NEW CHEMICAL COMPOUNDS (DERIVATIVES) AND THEIR APPLICATION FOR THE TREATMENT OF ONCOLOGICAL DISEASES BRAF, CNKSR1, RAF1 SLC6A4 4882/4885SLC6A2 4874/4885SLC6A3 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.